A detailed history of Clarus Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Clarus Group, Inc. holds 4,787 shares of MRK stock, worth $478,987. This represents 0.23% of its overall portfolio holdings.

Number of Shares
4,787
Previous 6,623 27.72%
Holding current value
$478,987
Previous $819,000 33.7%
% of portfolio
0.23%
Previous 0.36%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$111.15 - $128.97 $204,071 - $236,788
-1,836 Reduced 27.72%
4,787 $543,000
Q2 2024

Jul 19, 2024

BUY
$123.8 - $132.96 $25,750 - $27,655
208 Added 3.24%
6,623 $819,000
Q1 2024

Apr 22, 2024

SELL
$113.24 - $131.95 $40,313 - $46,974
-356 Reduced 5.26%
6,415 $846,000
Q4 2023

Jan 29, 2024

SELL
$100.18 - $109.02 $112,702 - $122,647
-1,125 Reduced 14.25%
6,771 $738,000
Q3 2023

Oct 16, 2023

SELL
$102.95 - $114.33 $99,655 - $110,671
-968 Reduced 10.92%
7,896 $812,000
Q2 2023

Jul 17, 2023

BUY
$108.61 - $118.38 $377,962 - $411,962
3,480 Added 64.64%
8,864 $1.02 Million
Q1 2023

Apr 18, 2023

BUY
$102.94 - $114.86 $1,235 - $1,378
12 Added 0.22%
5,384 $572,000
Q4 2022

Jan 27, 2023

BUY
$87.44 - $112.11 $1,399 - $1,793
16 Added 0.3%
5,372 $0
Q3 2022

Nov 09, 2022

BUY
$84.53 - $94.96 $1,183 - $1,329
14 Added 0.26%
5,356 $461,000
Q2 2022

Jul 27, 2022

BUY
$83.49 - $94.64 $1,335 - $1,514
16 Added 0.3%
5,342 $487,000
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $5,733 - $6,427
78 Added 1.49%
5,326 $437,000
Q4 2021

Feb 08, 2022

BUY
$72.28 - $90.54 $1,084 - $1,358
15 Added 0.29%
5,248 $393,000
Q2 2021

Aug 12, 2021

SELL
$70.31 - $77.77 $78,676 - $87,024
-1,119 Reduced 17.62%
5,233 $408,000
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $437,398 - $515,210
6,352 New
6,352 $484,000
Q1 2021

Apr 16, 2021

SELL
$68.86 - $81.11 $436,228 - $513,831
-6,335 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$71.77 - $79.65 $454,662 - $504,582
6,335 New
6,335 $475,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $253B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Clarus Group, Inc. Portfolio

Follow Clarus Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarus Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Clarus Group, Inc. with notifications on news.